合成及兰斯宁类似物的结构活性关系作为抗利什曼原虫药物。
Synthesis and structure-activity relationships of lansine analogues as antileishmanial agents.
机构信息
College of Pharmacy, University of Hawai'i at Hilo, Hilo, HI 96720-4029 (USA); Interdepartmental Center Biopharmanet_TEC, Universita' degli Studi di Parma, Via G. P. Usberti 27, Parma (Italy).
出版信息
ChemMedChem. 2012 Nov;7(11):1895-900. doi: 10.1002/cmdc.201200346. Epub 2012 Sep 17.
Abstract
Clear and rational thinking: A series of rationally designed, lansine-derived carbazoles was synthesized and evaluated for activity against promastigotes and amastigotes of Leishmania donovani, the causative agent of leishmaniasis. Some structural modifications gave rise to compounds with enhanced activity and selectivity over lansine, allowing structure-activity relationships to be elucidated and providing a foundation for the further development of this pharmacophore.
摘要
清晰理性的思考
我们设计并合成了一系列结构合理的源于 Lansine 的咔唑类化合物，评估其对引起利什曼病的利什曼原虫的前鞭毛体和无鞭毛体的活性。一些结构修饰使化合物的活性和选择性相对于 Lansine 增强，使我们能够阐明构效关系，并为进一步开发这一药效团提供了基础。
相似文献
1
Synthesis and structure-activity relationships of lansine analogues as antileishmanial agents.合成及兰斯宁类似物的结构活性关系作为抗利什曼原虫药物。
ChemMedChem. 2012 Nov;7(11):1895-900. doi: 10.1002/cmdc.201200346. Epub 2012 Sep 17.
2
Synthesis and biological evaluation of chalcones as potential antileishmanial agents.作为潜在抗利什曼原虫剂的查耳酮的合成与生物学评价
Eur J Med Chem. 2014 Jun 23;81:359-66. doi: 10.1016/j.ejmech.2014.05.034. Epub 2014 May 13.
3
Synthesis and biological evaluation of 4-chloro-3, 5-dinitrobenzotrifluoride analogues as antileishmanial agents.
J Med Chem. 1998 Nov 19;41(24):4885-9. doi: 10.1021/jm9804073.
4
Evaluation of synthetic substituted 1,2-dioxanes as novel agents against human leishmaniasis.评估合成取代的 1,2-二恶烷作为新型抗人类利什曼病药物。
Eur J Med Chem. 2019 May 15;170:126-140. doi: 10.1016/j.ejmech.2019.02.070. Epub 2019 Mar 3.
5
3D-Quantitative structure-activity relationships of synthetic antileishmanial ring-substituted ether phospholipids.合成抗利什曼原虫环状取代醚磷脂的3D-定量构效关系
Bioorg Med Chem. 2007 Feb 1;15(3):1252-65. doi: 10.1016/j.bmc.2006.11.018. Epub 2006 Nov 14.
6
Click inspired synthesis of antileishmanial triazolyl O-benzylquercetin glycoconjugates.点击反应促进抗利什曼原虫三唑基O-苄基槲皮素糖缀合物的合成。
Glycoconj J. 2015 May;32(3-4):127-40. doi: 10.1007/s10719-015-9582-x. Epub 2015 Apr 14.
7
Synthesis of oxysterols and nitrogenous sterols with antileishmanial and trypanocidal activities.具有抗利什曼原虫和杀锥虫活性的氧化甾醇和含氮甾醇的合成。
Eur J Med Chem. 2006 Oct;41(10):1109-16. doi: 10.1016/j.ejmech.2006.03.033. Epub 2006 Sep 1.
8
Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines.一系列 N²,N⁴-二取代喹唑啉-2,4-二胺的抗利什曼原虫活性。
J Med Chem. 2014 Jun 26;57(12):5141-56. doi: 10.1021/jm5000408. Epub 2014 Jun 17.
9
Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents.利什曼病的化学疗法第十三部分：新型杂环视黄醛 - 双苄叉丙酮杂化物作为抗利什曼原虫剂的设计与合成
Bioorg Med Chem Lett. 2015 Jan 15;25(2):410-3. doi: 10.1016/j.bmcl.2014.09.078. Epub 2014 Oct 2.
10
Design, Synthesis and Biological Evaluation of 7-arylbenzo[c]acridine-5,6- diones as Potential Anti-Leishmanial and anti-trypanosomal Agents.7-芳基苯并[c]吖啶-5,6-二酮作为潜在抗利什曼原虫和抗锥虫剂的设计、合成及生物学评价
Med Chem. 2018;14(6):563-572. doi: 10.2174/1573406414666180226163222.
引用本文的文献
1
Iodo-Cycloisomerization of Aryl(indol-3-yl)methane-Tethered Propargyl Alcohols to 3-Iodocarbazoles via Selective 1,2-Alkyl Migration.通过选择性1,2-烷基迁移将芳基（吲哚-3-基）甲烷连接的炔丙醇碘环异构化为3-碘咔唑。
ACS Omega. 2018 Nov 7;3(11):15024-15034. doi: 10.1021/acsomega.8b02393. eCollection 2018 Nov 30.
本文引用的文献
1
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.米替福新：一种治疗利什曼病的药理学和治疗功效的综述。
J Antimicrob Chemother. 2012 Nov;67(11):2576-97. doi: 10.1093/jac/dks275. Epub 2012 Jul 24.
2
Leishmaniasis: current status of available drugs and new potential drug targets.利什曼病：现有药物的现状和新的潜在药物靶点。
Asian Pac J Trop Med. 2012 Jun;5(6):485-97. doi: 10.1016/S1995-7645(12)60084-4.
3
Leishmania antimony resistance: what we know what we can learn from the field.利什曼原虫锑剂耐药性：我们所知与可从该领域借鉴之处。
Parasitol Res. 2011 Nov;109(5):1225-32. doi: 10.1007/s00436-011-2555-5. Epub 2011 Jul 29.
4
1,1'-(9-Octyl-9H-carbazole-3,6-di-yl)diethanone.1,1'-（9-辛基-9H-咔唑-3,6-二亚基）二乙酮
Acta Crystallogr Sect E Struct Rep Online. 2010 Jul 24;66(Pt 8):o2118. doi: 10.1107/S1600536810028928.
5
Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World.新世界皮肤利什曼病治疗不良反应的系统评价。
Acta Trop. 2011 May;118(2):87-96. doi: 10.1016/j.actatropica.2011.02.007. Epub 2011 Mar 21.
6
Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent.印度次大陆内脏利什曼病联合疗法的成本效益分析。
PLoS Negl Trop Dis. 2010 Sep 7;4(9):e818. doi: 10.1371/journal.pntd.0000818.
7
Synthesis, antibacterial and antifungal activities of some carbazole derivatives.咔唑衍生物的合成、抗菌和抗真菌活性。
Bioorg Med Chem Lett. 2010 Mar 15;20(6):1881-4. doi: 10.1016/j.bmcl.2010.01.159. Epub 2010 Feb 4.
8
Drug resistance in visceral leishmaniasis.内脏利什曼病中的耐药性。
J Biomed Biotechnol. 2010;2010:617521. doi: 10.1155/2010/617521. Epub 2009 Nov 1.
9
Natural product leads for drug discovery: isolation, synthesis and biological evaluation of 6-cyano-5-methoxyindolo[2,3-a]carbazole based ligands as antibacterial agents.天然产物先导药物发现：6-氰基-5-甲氧基吲哚并[2,3-a]咔唑类配体的分离、合成及作为抗菌剂的生物评价。
Bioorg Med Chem. 2009 Oct 15;17(20):7126-30. doi: 10.1016/j.bmc.2009.08.061. Epub 2009 Sep 4.
10
Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure--a case report and brief review of the literature.静脉注射戊烷脒和口服氟康唑治疗 HIV 阳性合并慢性肾衰竭患者内脏利什曼病：病例报告及文献复习
Int J Infect Dis. 2010 Jun;14(6):e522-5. doi: 10.1016/j.ijid.2009.06.010. Epub 2009 Sep 1.
Zotero 插件